Ding v. Roka Bioscience, Inc., No. 14-8020 (FLW)

The Rosen Law Firm was sole Lead Counsel in this class action in the U.S. District Court for District of New Jersey. The complaint alleges violations of §§11 and 15 of the Securities Act arising out of the Company’s issuance of materially false and misleading business information. The parties agreed to settle this case for $3.275 million in cash.

Scroll to Top